Trial intelligence / Profile preview

Intranasal Oxytocin Effects on Social Touch

NCT03278860Unknown

Sponsor
University of Electronic Science and Technology of China
Start
Aug 2017
Primary completion
Aug 2019
Countries
1
01

Overview

Randomised, double-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) and Social Anxiety Disorder (SAD) (2 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoint: fMRI-based measures of interoceptive and reward processing. Status: unknown.

02

Drugs

oxytocin nasal spray
03

Conditions

Autism Spectrum Disorder (ASD)Social Anxiety Disorder (SAD)

Beyond the preview

Go deeper on NCT03278860.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03278860.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call